Resources

Epanova®   FDA Approves A Different Form of Omega-3. Epanova is the first FDA-approved prescription omega-3 in free fatty acid. The approval of Epanova is good news for the significant and growing population with severe hypertriglyceridemia as it offers physicians and their patients an important new treatment option that has …

In a head to head 3 phase study, basal insulin peglispro (BIL) outperforms the leading basal insulin for type 2 diabetes…. 

Improvements seen in peripheral insulin sensitivity and hepatic insulin extraction….

Acetate, a molecule released during the digestion of fiber, triggers a "hunger stop" command to the brain….

The Food and Drug Administration last week stated that aspirin should not be used for stroke or heart attack prevention in people with no history of heart disease…. 

Consuming low-carbohydrate diets can reduce inflammation in patients with type 2 diabetes which may decrease the risk of patients developing cardiovascular disease…. 

AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Epanova (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridaemia (triglyceride levels greater than or equal to 500 mg/dL)…. 

An advanced framework for a new diagnostic approach to obesity was announced last week by the American Association of Clinical Endocrinologists (AACE) at their 23rd Scientific and Clinical Congress…. 

Exposure to diabetes in utero may significantly impair beta-cell function in children…. 

The antioxidant resveratrol, found in red wine, chocolate and grapes, was not associated with longevity or the incidence of cardiovascular disease, cancer and inflammation in a new study….